COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients

Zhonghua Shi, Sylvia J. P. Bogaards, Stefan Conijn, Y. L. Onderwater, Pedro Espinosa, Diewertje I. Bink, Marloes van den Berg, Martijn van de Locht, Marianna Bugiani, Hans van der Hoeven,

BMJ Open Respiratory Research · 2021 · 13 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

INTRODUCTION: The diaphragm is the main muscle of inspiration, and its dysfunction contributes to adverse clinical outcomes in critically ill patients. We recently reported the infiltration of SARS-CoV-2, and the development of fibrosis, in the diaphragm of critically ill patients with COVID-19. In the current study, we aimed to characterise myofiber structure in the diaphragm of critically ill patients with COVID-19. METHODS: Diaphragm muscle specimens were collected during autopsy from patients who died of COVID-19 in three academic medical centres in the Netherlands in April and May 2020 (n=27). We studied diaphragm myofiber gene expression and structure and compared the findings obtained to those of deceased critically ill patients without COVID-19 (n=10). RESULTS: ). Four critically ill patients with COVID-19 showed extremely large myofibers, which were splitting and contained many centralised nuclei. RNA-sequencing data revealed differentially expressed genes involved in muscle regeneration. CONCLUSION: Diaphragm of critically ill patients with COVID-19 has distinct myopathic features compared with critically ill patients without COVID-19, which may contribute to the ongoing dyspnoea and fatigue in the patients surviving COVID-19 infection.

References

9